Tokyo Tape
Sign in
← Terumo

Half-year report · Q2

4543.TEDINET S100UOKT
Period2024-04-01 → 2024-09-30
Filed2024-11-11
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥508.7bn2024-04-01 → 2024-09-30Cons.Revenue IFRS
Revenue¥921.9bn2023-04-01 → 2024-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥443.9bn2023-04-01 → 2023-09-30Cons.Revenue IFRS
Operating income¥87.7bn2024-04-01 → 2024-09-30Cons.Operating profit loss IFRS
Operating income¥66.5bn2023-04-01 → 2023-09-30Cons.Operating profit loss IFRS
Profit before tax¥85.1bn2024-04-01 → 2024-09-30Cons.Profit loss before tax IFRS
Profit before tax¥140.8bn2023-04-01 → 2024-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥66.4bn2023-04-01 → 2023-09-30Cons.Profit loss before tax IFRS
Net income (owners)¥63.2bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥106.4bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥50.1bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥63.2bn2024-04-01 → 2024-09-30Cons.Profit loss IFRS
Net income¥50.1bn2023-04-01 → 2023-09-30Cons.Profit loss IFRS
Total assets¥1.75Tat 2024-09-30Cons.Assets IFRS
Total assets¥1.83Tat 2024-03-31Cons.Assets IFRS
Total assets¥1.75Tat 2023-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥438.8bnat 2024-09-30Cons.Liabilities IFRS
Total liabilities¥504.3bnat 2024-03-31Cons.Liabilities IFRS
Net assets / equity¥1.31Tat 2024-09-30Cons.Equity IFRS
Net assets / equity¥1.33Tat 2024-03-31Cons.Equity IFRS
Net assets / equity¥1.26Tat 2023-09-30Cons.Equity IFRS
Net assets / equity¥1.11Tat 2023-03-31dCons.Equity IFRS
Equity (owners)¥1.31Tat 2024-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.33Tat 2024-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.26Tat 2023-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥194.9bnat 2024-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥204.9bnat 2024-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥187.3bnat 2023-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥187.3bnat 2023-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥100.9bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥146.3bn2023-04-01 → 2024-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥53.6bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥38.8bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥81.5bn2023-04-01 → 2024-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥36.1bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥65.4bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥62.1bn2023-04-01 → 2024-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥30.0bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥42.572024-04-01 → 2024-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥71.52023-04-01 → 2024-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥33.632023-04-01 → 2023-09-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥42.562024-04-01 → 2024-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥71.472023-04-01 → 2024-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥33.622023-04-01 → 2023-09-30Cons.Diluted earnings loss per share IFRS
Equity ratio75.0%at 2024-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio72.5%at 2024-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio72.1%at 2023-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue external2024-04-01 → 2024-09-30¥132m
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30¥1.2bn
jpcrp040300-q2r_E01630-000Blood And Cell Technologies Companyreportable segmentrevenue external2024-04-01 → 2024-09-30¥98.0bn
jpcrp040300-q2r_E01630-000Blood And Cell Technologies Companyreportable segmentsegment profit2024-04-01 → 2024-09-30¥13.2bn
jpcrp040300-q2r_E01630-000Cardiac And Vascular Companyreportable segmentrevenue external2024-04-01 → 2024-09-30¥306.3bn
jpcrp040300-q2r_E01630-000Cardiac And Vascular Companyreportable segmentsegment profit2024-04-01 → 2024-09-30¥76.9bn
jpcrp040300-q2r_E01630-000Medical Care Solutions Companyreportable segmentrevenue external2024-04-01 → 2024-09-30¥104.3bn
jpcrp040300-q2r_E01630-000Medical Care Solutions Companyreportable segmentsegment profit2024-04-01 → 2024-09-30¥12.7bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥508.6bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥102.8bn
Reconciling Itemsreconcilingrevenue external2023-04-01 → 2023-09-30¥119m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥1.0bn
jpcrp040300-q2r_E01630-000Blood And Cell Technologies Companyreportable segmentrevenue external2023-04-01 → 2023-09-30¥84.1bn
jpcrp040300-q2r_E01630-000Blood And Cell Technologies Companyreportable segmentsegment profit2023-04-01 → 2023-09-30¥10.6bn
jpcrp040300-q2r_E01630-000Cardiac And Vascular Companyreportable segmentrevenue external2023-04-01 → 2023-09-30¥265.7bn
jpcrp040300-q2r_E01630-000Cardiac And Vascular Companyreportable segmentsegment profit2023-04-01 → 2023-09-30¥57.6bn
jpcrp040300-q2r_E01630-000Medical Care Solutions Companyreportable segmentrevenue external2023-04-01 → 2023-09-30¥94.0bn
jpcrp040300-q2r_E01630-000Medical Care Solutions Companyreportable segmentsegment profit2023-04-01 → 2023-09-30¥8.3bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥443.8bn
—segment totalsegment profit2023-04-01 → 2023-09-30¥76.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 637
ItemContextValueUnit
Profit loss IFRSCurrentYTDDuration63204000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration661000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration805000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration123000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration-27000000JPY
Total of items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration784000000JPY
Total of items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration778000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration114426000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration-59194000000JPY
Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration269000000JPY
Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration-5000000JPY
Cost of hedging net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration-170000000JPY
Cost of hedging net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration56000000JPY
Total of items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration114525000000JPY
Total of items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration-59142000000JPY
Other comprehensive income IFRSPrior1YTDDuration115310000000JPY
Other comprehensive income IFRSCurrentYTDDuration-58363000000JPY
Comprehensive income IFRSPrior1YTDDuration165402000000JPY
Comprehensive income IFRSCurrentYTDDuration4840000000JPY
Comprehensive income attributable to owners of parent IFRSPrior1YTDDuration165402000000JPY
Comprehensive income attributable to owners of parent IFRSCurrentYTDDuration4840000000JPY
Comprehensive income IFRSPrior1YTDDuration165402000000JPY
Comprehensive income IFRSCurrentYTDDuration4840000000JPY
Equity IFRSPrior2YearInstant_ShareCapitalIFRSMember38716000000JPY
Equity IFRSPrior2YearInstant_CapitalSurplusIFRSMember51759000000JPY
Equity IFRSPrior2YearInstant_TreasurySharesIFRSMember-11539000000JPY
Equity IFRSPrior2YearInstant_RetainedEarningsIFRSMember874272000000JPY
Equity IFRSPrior2YearInstant_OtherComponentsOfEquityIFRSMember157855000000JPY
Equity IFRSPrior2YearInstant_EquityAttributableToOwnersOfParentIFRSMember1111063000000JPY
Equity IFRSPrior2YearInstant1111063000000JPY
Profit loss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember50092000000JPY
Profit loss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember50092000000JPY
Profit loss IFRSPrior1YTDDuration50092000000JPY
Other comprehensive income IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_RetainedEarningsIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember115310000000JPY
Other comprehensive income IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember115310000000JPY
Other comprehensive income IFRSPrior1YTDDuration115310000000JPY
Comprehensive income IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_RetainedEarningsIFRSMember50092000000JPY
Comprehensive income IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember115310000000JPY
Comprehensive income IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember165402000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2024-03-31pass rounding
balance sheet identityconsolidated 2024-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass